Vanguard Global Advisers’s X4 Pharmaceuticals XFOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$96.8K Buy
33,393
+416
+1% +$1.61K ﹤0.01% 2789
2026
Q2
$154K Hold
32,977
– – ﹤0.01% 2606
2026
Q1
$136K Buy
+32,977
New +$124K ﹤0.01% 2598

Other funds holding XFOR

Vanguard Global Advisers's XFOR Position: Q3 2026 in Review

Vanguard Global Advisers increased its X4 Pharmaceuticals (XFOR) stake by 1.3% in Q3 2026, buying an estimated $1.61K and bringing the position to 33,393 shares worth $96.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2789.

Vanguard Global Advisers first reported a position in XFOR in Q1 2026 and has held it in 3 quarters since. The position peaked at $154K in Q2 2026. 97 funds tracked by Wall St. Rank hold XFOR as of Q3 2026.

  • Vanguard Global Advisers held 33,393 shares of X4 Pharmaceuticals worth $96.8K as of Q3 2026.
  • Vanguard Global Advisers bought 416 X4 Pharmaceuticals shares in Q3 2026, an estimated $1.61K.
  • X4 Pharmaceuticals made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2789 holding.
  • Vanguard Global Advisers first reported a position in X4 Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's X4 Pharmaceuticals position peaked at $154K in Q2 2026.
  • 97 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.